Joint Clinical Trials Office

You are here

rTMS Augmentation of Escitalopram in Depression Executive Dysfunction Syndrome

Clinical Trial Details

This study is being done because there is evidence that some people with depression can improve following stimulation to the brain using a treatment called Repetitive Transcranial Magnetic Stimulation or rTMS. The purpose of this study is to see whether rTMS may improve the ability of an antidepressant medication, escitalopram, to treat late-life depression in individuals with certain types of cognitive problems. Currently, it is unknown whether rTMS adds to the benefit of escitalopram for individuals with this type of depression.

Key Eligibility: 
  • Between 50 and 90 years old
  • Have been diagnosed with depression
  • Detailed criteria will be reviewed with study team

Study contact by location

Upper East Side - Manhattan

Contact(s)

Irena Ilieva
212-821-0778
iri9005@med.cornell.edu

Primary Investigator(s)

Protocol ID(s)

Weill Cornell Medicine IRB #:

1506016320

Status

Open to Enrollment

Age Group

Adult

Disease